Pyxis Oncology, Inc. (PYXS) — Operating Cash Flow
| Fiscal Year | Operating Cash Flow | Change YoY |
|---|---|---|
| 2025 | -$63.50M | -10.1% |
| 2024 | -$57.67M | +18.4% |
| 2023 | -$70.71M | +20.8% |
| 2022 | -$89.33M | -152.9% |
| 2021 | -$35.33M | -250.3% |
| 2020 | -$10.08M | — |
| Fiscal Year | Operating Cash Flow | Change YoY |
|---|---|---|
| 2025 | -$63.50M | -10.1% |
| 2024 | -$57.67M | +18.4% |
| 2023 | -$70.71M | +20.8% |
| 2022 | -$89.33M | -152.9% |
| 2021 | -$35.33M | -250.3% |
| 2020 | -$10.08M | — |